330 related articles for article (PubMed ID: 24350616)
41. Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine.
Hao L; Wu Y; Zhang Y; Zhou Z; Lei Q; Ullah N; Banga Ndzouboukou JL; Lin X; Fan X
Front Immunol; 2020; 11():575504. PubMed ID: 33117374
[TBL] [Abstract][Full Text] [Related]
42. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells.
Lindenstrøm T; Agger EM; Korsholm KS; Darrah PA; Aagaard C; Seder RA; Rosenkrands I; Andersen P
J Immunol; 2009 Jun; 182(12):8047-55. PubMed ID: 19494330
[TBL] [Abstract][Full Text] [Related]
43. Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powder.
Thakur A; Ingvarsson PT; Schmidt ST; Rose F; Andersen P; Christensen D; Foged C
Vaccine; 2018 May; 36(23):3331-3339. PubMed ID: 29699790
[TBL] [Abstract][Full Text] [Related]
44. Subunit vaccine consisting of multi-stage antigens has high protective efficacy against Mycobacterium tuberculosis infection in mice.
Xin Q; Niu H; Li Z; Zhang G; Hu L; Wang B; Li J; Yu H; Liu W; Wang Y; Da Z; Li R; Xian Q; Wang Y; Zhang Y; Jing T; Ma X; Zhu B
PLoS One; 2013; 8(8):e72745. PubMed ID: 23967337
[TBL] [Abstract][Full Text] [Related]
45. Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis.
Bertholet S; Ireton GC; Kahn M; Guderian J; Mohamath R; Stride N; Laughlin EM; Baldwin SL; Vedvick TS; Coler RN; Reed SG
J Immunol; 2008 Dec; 181(11):7948-57. PubMed ID: 19017986
[TBL] [Abstract][Full Text] [Related]
46. ESAT-6 Targeting to DEC205+ Antigen Presenting Cells Induces Specific-T Cell Responses against ESAT-6 and Reduces Pulmonary Infection with Virulent Mycobacterium tuberculosis.
Silva-Sánchez A; Meza-Pérez S; Flores-Langarica A; Donis-Maturano L; Estrada-García I; Calderón-Amador J; Hernández-Pando R; Idoyaga J; Steinman RM; Flores-Romo L
PLoS One; 2015; 10(4):e0124828. PubMed ID: 25915045
[TBL] [Abstract][Full Text] [Related]
47. Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3.
Romano M; Roupie V; Wang XM; Denis O; Jurion F; Adnet PY; Laali R; Huygen K
Immunology; 2006 Jul; 118(3):321-32. PubMed ID: 16827893
[TBL] [Abstract][Full Text] [Related]
48. Phosphatidylinositol di-mannoside and derivates modulate the immune response to and efficacy of a tuberculosis protein vaccine against Mycobacterium bovis infection.
Parlane NA; Compton BJ; Hayman CM; Painter GF; Basaraba RJ; Heiser A; Buddle BM
Vaccine; 2012 Jan; 30(3):580-8. PubMed ID: 22120192
[TBL] [Abstract][Full Text] [Related]
49. Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins.
Xiang ZH; Sun RF; Lin C; Chen FZ; Mai JT; Liu YX; Xu ZY; Zhang L; Liu J
Front Cell Infect Microbiol; 2017; 7():226. PubMed ID: 28620588
[TBL] [Abstract][Full Text] [Related]
50. B Cells and Programmed Death-Ligand 2 Signaling Are Required for Maximal Interferon-γ Recall Response by Splenic CD4⁺ Memory T Cells of Mice Vaccinated with Mycobacterium tuberculosis Ag85B.
Riccomi A; Palma C
PLoS One; 2015; 10(9):e0137783. PubMed ID: 26379242
[TBL] [Abstract][Full Text] [Related]
51. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
[TBL] [Abstract][Full Text] [Related]
52. A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge.
Gao H; Yue Y; Hu L; Xu W; Xiong S
Vaccine; 2009 Aug; 27(39):5313-9. PubMed ID: 19615961
[TBL] [Abstract][Full Text] [Related]
53. Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells.
Derrick SC; Yabe IM; Yang A; Morris SL
Vaccine; 2011 Apr; 29(16):2902-9. PubMed ID: 21338678
[TBL] [Abstract][Full Text] [Related]
54. Rescuing ESAT-6 Specific CD4 T Cells From Terminal Differentiation Is Critical for Long-Term Control of Murine Mtb Infection.
Clemmensen HS; Knudsen NPH; Billeskov R; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Mortensen R
Front Immunol; 2020; 11():585359. PubMed ID: 33240275
[TBL] [Abstract][Full Text] [Related]
55. Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine.
Mosavat A; Soleimanpour S; Farsiani H; Sadeghian H; Ghazvini K; Sankian M; Jamehdar SA; Rezaee SA
Infect Genet Evol; 2016 Apr; 39():163-172. PubMed ID: 26835592
[TBL] [Abstract][Full Text] [Related]
56. A Promising Listeria-Vectored Vaccine Induces Th1-Type Immune Responses and Confers Protection Against Tuberculosis.
Yin Y; Lian K; Zhao D; Tao C; Chen X; Tan W; Wang X; Xu Z; Hu M; Rao Y; Zhou X; Pan Z; Zhang X; Jiao X
Front Cell Infect Microbiol; 2017; 7():407. PubMed ID: 29034213
[TBL] [Abstract][Full Text] [Related]
57. Intradermal immunization improves protective efficacy of a novel TB vaccine candidate.
Baldwin SL; Bertholet S; Kahn M; Zharkikh I; Ireton GC; Vedvick TS; Reed SG; Coler RN
Vaccine; 2009 May; 27(23):3063-71. PubMed ID: 19428920
[TBL] [Abstract][Full Text] [Related]
58. CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination.
Elvang T; Christensen JP; Billeskov R; Thi Kim Thanh Hoang T; Holst P; Thomsen AR; Andersen P; Dietrich J
PLoS One; 2009; 4(4):e5139. PubMed ID: 19357780
[TBL] [Abstract][Full Text] [Related]
59. A novel vaccine p846 encoding Rv3615c, Mtb10.4, and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium infection.
Kong H; Dong C; Xiong S
Hum Vaccin Immunother; 2014; 10(2):378-90. PubMed ID: 24280763
[TBL] [Abstract][Full Text] [Related]
60. Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein.
Lu J; Wang C; Zhou Z; Zhang Y; Cao T; Shi C; Chen Z; Chen L; Cai C; Fan X
Clin Dev Immunol; 2011; 2011():617892. PubMed ID: 21461375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]